ArticleCurrent protocols2026
An In Vitro Model of Macrophage Senescence.
Article in Current protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An In Vitro Model of Macrophage Senescence.Current protocols · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
We present a reproducible in vitro protocol for harvesting and culturing murine bone marrow-derived macrophages, with the added capability of freezing bone marrow cells at -80°C for scalability and long-term storage. To induce macrophage senescence, we developed a genotoxic stress-based method using either 10 Gy ionizing radiation or 500 nM doxorubicin treatment. The resulting senescent macrophages exhibit key hallmarks of cellular senescence, including irreversible cell cycle arrest, upregulation of senescence-associated markers (e.g., Cdkn1a), secretion of senescence-associated secretory phenotype (SASP) factors, morphological changes, and SA-β-galactosidase activity. This model serves as a valuable tool for investigating macrophage senescence, a relatively understudied senescent cell type, and provides mechanistic insights into the contribution of the innate immune system to aging and age-related diseases. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Mouse dissection and bone marrow harvest Basic Protocol 2: Thawing and plating cryopreserved murine bone marrow for macrophage differentiation Support Protocol 1: Flow cytometry validation of macrophage surface markers Support Protocol 2: Gene expression analysis via RT-qPCR Basic Protocol 3: Inducing senescence in macrophages using doxorubicin or irradiation Alternate Protocol: Maintenance and expansion of control macrophages Support Protocol 3: Brightfield microscopy and SA-β-galactosidase staining to assess senescence-associated morphology Support Protocol 4: Quantifying senescence and SASP marker expression by qPCR and/or western blot Support Protocol 5: Assessment of cell cycle arrest using EdU labeling with optional DNA content staining.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.